Original Article
Venkateswara Rao Vallu, Krunal
Abstract
Febuxostat is indicated use for the treatment of hyperuricemia and gout. During the process development of Febuxostat, ten process related analogues were observed at a level of 0.1-0.15 area percent. Synthesis and characterization of these analogues and investigation of the root cause of their formation is described.